Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05406_nanopub.RANU-MR_hND5fbJlPa7sDZLmzQHLptVeJs5PZR-KNcFf0#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05406 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05406 label "GTI-2501 [drugbank:DB05406]" assertion.
- drugbank:DB05406 seeAlso DB05406 assertion.
- drugbank:DB05406 description "GTI-2501 is a novel antisense drug which has shown a favorable safety profile in preclinical studies, and in a phase I clinical trial. The drug is in a phase II clinical trial in combination with docetaxel for the treatment of hormone refractory prostate cancer. Initial testing has demonstrated strong antitumor activity in preclinical studies in prostate cancer and a variety of other tumor types." assertion.
- drugbank:DB05406 identifier "drugbank:DB05406" assertion.
- drugbank:DB05406 title "GTI-2501" assertion.
- drugbank:DB05406 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05406 drugbank_vocabulary:drugbank-id "DB05406" assertion.
- drugbank:DB05406 bio2rdf_vocabulary:x-identifiers.org DB05406 assertion.
- drugbank:DB05406 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05406" assertion.
- drugbank:DB05406 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05406 bio2rdf_vocabulary:identifier "DB05406" assertion.